Author Archives: Mark Senak

COVID-19 Vaccinations – Where a Commitment to Diversity is Essential

In my last posting on preparedness for a post-vaccination world I touched on some of the questions facing employers in general – policy questions that should be considered now for the eventualities of later. But digging a little deeper, there … Continue reading

Posted in Uncategorized | Tagged | Leave a comment

As the Prospect of a Vaccine Approaches, Business and Communications Challenges Are Just Around the Corner

Coincident to COVID-19 case levels in Europe and the United States entering new and serious levels comes welcome news on the development of a vaccine. Last week Pfizer and BioNTech announced findings from the first interim analysis of the Phase … Continue reading

Posted in Current Affairs | Tagged | Comments Off on As the Prospect of a Vaccine Approaches, Business and Communications Challenges Are Just Around the Corner

FDA AdComm Agenda Covers the Bases

First of all, we are having a bit of a crisis with our crisis. As we appear to be moving into yet another wave of COVID-19 infections, and as research into a vaccine is aggressively underway, we also see serious … Continue reading

Posted in Advisory Committee Prepapartion, COVID19, Current Affairs, FDA Image, FDA Policy | Tagged | Comments Off on FDA AdComm Agenda Covers the Bases

After a Vaccine – What? The Shift from Research and Discovery to Communications

Vaccines for COVID-19 are the focus of the moment – politically and scientifically speaking. On the political front, there has not only been jockeying to try to squeeze the square peg of a vaccine development timeline into a round hole … Continue reading

Posted in Uncategorized | Tagged | Comments Off on After a Vaccine – What? The Shift from Research and Discovery to Communications

For FDA and CDC and the Rest of Us – The Stakes Have Never Been Higher

Since last week’s posting regarding FDA credibility being on the line, there has been a swirl of activity and commentary around the evaluation of vaccine research for COVID-19 that would seem to have exacerbated the problem. For context, last week … Continue reading

Posted in Uncategorized | Tagged , , , , | Comments Off on For FDA and CDC and the Rest of Us – The Stakes Have Never Been Higher